Xeris Biopharma Holdings (XERS) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Xeris Biopharma Holdings (XERS) over the last 6 years, with Q3 2025 value amounting to -$91.6 million.
- Xeris Biopharma Holdings' Enterprise Value fell 3198.18% to -$91.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$91.6 million, marking a year-over-year decrease of 3198.18%. This contributed to the annual value of -$71.6 million for FY2024, which is 114.56% up from last year.
- As of Q3 2025, Xeris Biopharma Holdings' Enterprise Value stood at -$91.6 million, which was down 3198.18% from -$59.3 million recorded in Q2 2025.
- Xeris Biopharma Holdings' Enterprise Value's 5-year high stood at -$58.4 million during Q1 2025, with a 5-year trough of -$132.1 million in Q1 2022.
- Over the past 5 years, Xeris Biopharma Holdings' median Enterprise Value value was -$87.4 million (recorded in 2024), while the average stood at -$87.3 million.
- Per our database at Business Quant, Xeris Biopharma Holdings' Enterprise Value plummeted by 14542.84% in 2021 and then surged by 4059.74% in 2023.
- Xeris Biopharma Holdings' Enterprise Value (Quarter) stood at -$102.4 million in 2021, then fell by 19.07% to -$122.0 million in 2022, then skyrocketed by 40.6% to -$72.5 million in 2023, then grew by 1.15% to -$71.6 million in 2024, then fell by 27.89% to -$91.6 million in 2025.
- Its Enterprise Value stands at -$91.6 million for Q3 2025, versus -$59.3 million for Q2 2025 and -$58.4 million for Q1 2025.